Inverse associations are reported between circulating 25-hydroxyvitamin D and visceral adiposity. The effects of vitamin D levels on atherosclerosis are unknown.
M
arked ethnic differences exist in bone metabolism and development of calcified atherosclerotic plaque (CP). Relative to European-Americans, African-Americans have lower rates of osteoporosis (despite ingesting less dietary calcium), form fewer calcium-containing kidney stones and manifest skeletal resistance to PTH (1) (2) (3) . Systemic differences in regulation of calcium and phosphorus appear to be involved (4) . Related phenomena may include the markedly lower amounts of calcified CP in African-Americans, despite the presence of more severe conventional cardiovascular disease risk factors (5) (6) (7) (8) (9) . Together these observations suggest biologically mediated ethnic differences in the regulation of bone and vascular health.
Vitamin D is critically important for absorption of dietary calcium and phosphorus in the gastrointestinal tract to maintain bone health. Vitamin D receptors are also present on heart, stomach, liver, brain, skin, pancreatic islets (␤ cells), thyroid, parathyroid, adrenal gland, and immune cells (10) , and low vitamin D levels have been associated with diabetes (11, 12) , inflammation (13) , hypertension (14 -17) , and subclinical atherosclerosis (18) . Low levels of vitamin D are far more common in African-Americans than European-Americans (19 -21) , and supplementation is typically recommended in those with 25-hydroxyvitamin D levels less than 74.9 nmol/liter (30 ng/ml) (22) . Low levels of 25-hydroxyvitamin D are associated with increased mortality in predominantly non-African-derived populations (23) .
Inverse relationships between bone density and CP have been observed in predominantly European-derived populations (24 -29) . Inverse relationships have also been observed between visceral adiposity and vitamin D in Europeans (30) and more recently in African-Americans and Hispanics (31, 32) . It remains unclear whether circulating vitamin D levels relate to bone density or CP in African-derived populations. The African American-Diabetes Heart Study is exploring the inherited and environmental causes of CP in African-Americans with longstanding type 2 diabetes mellitus and preserved kidney function. We measured circulating forms of vitamin D, highly sensitive C-reactive protein (hsCRP) and intact PTH as well as determined regional adipose tissue volumes, CP, and thoracic and lumbar vertebral bone density using computed tomography (CT). Relationships between organ-specific adipose tissue and vascular CP with vitamin D, CRP, and intact PTH were assessed.
Subjects and Methods

Study populations
African-Americans with type 2 diabetes recruited in the African American-Diabetes Heart Study formed the study population. Diabetes was diagnosed after the age of 30 yr in the absence of historical evidence of ketoacidosis. Subjects who underwent prior coronary artery bypass surgery or carotid endarterectomy had that vascular bed excluded from analysis because it was felt that the CP in the relevant arteries would be impacted by these procedures. Participants with prior myocardial infarction or stroke were included. The study was approved by the Institutional Review Board at the Wake Forest University School of Medicine, and all participants provided written informed consent.
Examinations were conducted in the General Clinical Research Center of the Wake Forest University School of Medicine and included interviews for medical history, current medications and health behaviors, measurements of body size, resting blood pressure, 12-lead electrocardiogram, fasting blood draw, and spot urine collection. Laboratory assays included urine albumin and creatinine, total cholesterol, low-density lipoprotein, highdensity lipoprotein, triglycerides, hemoglobin A1c (HbA 1c ), hsCRP, blood urea nitrogen, serum glucose, creatinine, albumin, calcium, phosphorus, 25-hydroxyvitamin D, 1,25 dihydroxyvitamin D, and intact PTH. The vitamin D assays were developed and performance characteristics determined by Quest Diagnostics Nichols Institute (San Juan Capistrano, CA). The 25-hydroxyvitamin D assay was performed using liquid chromatography tandem mass spectroscopy and a radioreceptor assay was used for 1,25 dihydroxyvitamin D. Intra-and interassay coefficients of variation for 25-hydroxyvitamin D are: (low control ϭ 49.9 -62.4 nmol/liter; medium control ϭ 112.3-137.3 nmol/ liter; high control ϭ 237.1-262.1 nmol/liter; acceptance Յ15%), interassay, low ϭ 9.7% (D2), 13.5% (D3); medium ϭ 11.6% (D2), 10.7% (D3); high ϭ 8.8% (D2), 8.4% (D3); and intraassay, low ϭ 9.0% (D2), 11.2% (D3); medium ϭ 6.9% (D2), 7.5% (D3); high ϭ 8.1% (D2), 8.5% (D3). Intra-and interassay coefficients of variation for 1,25 dihydroxyvitamin D are: (low control ϭ 65-91 pmol/liter; medium control ϭ 143-169 pmol/ liter; high control ϭ 286 -338 pmol/liter); results were: interassay, low ϭ 19% (D2), 13% (D3); medium ϭ 17% (D2), 10% (D3); high ϭ 11% (D2), 6% (D3) and intraassay, low ϭ 15% (D2), 7% (D3); medium ϭ 13% (D2), 10% (D3); and high ϭ 11% (D2), 7% (D3). Modification of Diet in Renal Disease estimated glomerular filtration rates (GFRs) were computed (33) . History of cardiovascular disease was provided by participant self-report.
Vascular imaging
Calcified atherosclerotic plaque was measured in the coronary, carotid, and infrarenal abdominal aorta arteries with single and multidetector CT systems using a standard electrocardiogram-gated CT scanning protocol based on those currently implemented in the National Heart, Lung, and Blood Institute's Multi-Ethnic Study of Atherosclerosis (MESA) (34) . The calcium mass score (SmartScore; General Electric Healthcare, Waukesha, WI), accounting for the volume and density of CP on a pixel-by-pixel basis and highly correlated with the standard Agatston score using a 90 Hounsfield unit threshold, 0.5 mm 2 minimum lesion size (two adjacent pixels) was used for comparability between vascular territories.
Adipose tissue imaging
Pericardial adipose tissue (PAT) and visceral adipose tissue (VAT) were measured from volumetric CT acquisitions to reduce variability related to slice location using the Volume Analysis software (Advantage Windows Workstation, GE Healthcare) and a threshold of Ϫ190 to Ϫ30 as the definitions of fat containing tissue. PAT is the combined adipose tissue superficial (paracardial) and deep (epicardial) to the pericardium; however, the pericardium extends superiorly to encase the great vessels and inferiorly borders the diaphragm (35) . Our methods for measuring PAT segments a volume for measurement that covers 45 mm in length along the z-axis (cephalocaudad) of the individual based on origin of the left main coronary such that it extends 15 mm above and 30 mm below. This PAT volume includes the majority of the coronary arteries and myocardium and excludes PAT located superiorly around the aorta and pulmonary arteries and adjacent to the abdomen, as reported (36) .
In the abdomen, VAT, sc adipose tissue (SAT), and intermuscular adipose tissue (IMAT) were measured on abdominal CT scans with technical factors: helical mode, 120 kVp, 250 mA, 4 ϫ 2.5 mm collimation, standard reconstruction kernel, and a display field of view of 500 mm. The landmark for analysis was the first lumbar disk above the lumbar-sacrum junction, most commonly designated as L4-L5. A volume 15 mm in z-axis length of the abdomen was segmented for the sc, abdominal wall, and intraabdominal compartments. VAT was defined as the fat containing pixels located within the abdominal cavity, SAT was defined as the fat containing pixels between the skin surface and lean tissue of the abdominal wall, and IMAT was measured within the abdominal wall and paraspinal muscles. Studies in human cadavers revealed that the area measured by CT is an accurate estimate of VAT, SAT, and IMAT volume.
Bone imaging
Quantitative CT for volumetric trabecular bone mineral density (BMD; milligrams per cubic centimeter) of the thoracic and lumbar vertebrae were measured using images obtained for CP in the coronary and abdominal aorta, including an external calibration phantom as in previous reports. Detailed descriptions have been published (37) .
Statistical methods
Generalized linear models were fitted to test for associations between circulating 25-hydroxyvitamin D, 1,25 dihydroxyvitamin D, hsCRP, and intact PTH treated separately as predictors with PAT, VAT, IMAT, and SAT; thoracic and lumbar vertebral BMD; and aorta, coronary, and carotid artery CP (38) . The BoxCox method was applied to identify the appropriate transformation of each outcome variable that would best approximate the distributional assumptions of conditional normality and homogeneity of variance of the residuals (39) . The natural log of (coronary CPϩ1), (carotid CPϩ1), (aorta CPϩ1), (IMATϩ1), (PATϩ1), (urine albumin to creatinine ratioϩ1), and (thoracic BMDϩ1) as well as the square root of (VAT) and (lumbar BMD) were analyzed. There was no need to transform GFR and SAT. Before these transformations, observed values of aorta, carotid, and coronary CP exceeding the 95th percentile were winsorized at their 95th percentile. Analyses were run without adjustment, adjusting for age and gender and adjusting for age, gender, body mass index, GFR, and HBA 1c . Because the adjustments did not affect the parameter estimates significantly, we show only results obtained using the fully adjusted model. Standard regression diagnostics for collinearity and influence were computed for each model reported.
Results
The study population consisted of 340 unrelated AfricanAmericans with type 2 diabetes mellitus. Demographic characteristics of the 140 men and 200 women are listed in Table 1 . Two participants had undergone carotid endarterectomy and 17 coronary artery bypass surgery; these 19 vascular beds were excluded from analysis. Table 3 contains the results of analyses comparing relationships between vitamin D levels, intact PTH, and hsCRP vs. organ-specific adipose tissue volume. In the fully adjusted model (age, gender, body mass index, HbA 1c , and GFR adjusted), a negative association was observed between 25-hydroxyvitamin D and VAT (P ϭ 0.009); similar relationships were seen in men and women (P ϭ 0.046 and 0.039, respectively, data not shown). In addition, nonsignificant trends toward a negative relationship between 25-hydroxyvitamin D with SAT (P ϭ 0.153) and IMAT (P ϭ 0.083) were observed. Serum hsCRP was positively associated with IMAT (P ϭ 0.015). Table 4 contains results of association analyses between vitamin D, intact PTH, and CRP with vertebral bone density and aorta, coronary and carotid artery CP. 25-Hydroxyvitamin D was positively associated with both carotid artery CP and aorta CP (P ϭ 0.013 and 0.014, respectively) but not bone density or coronary artery CP. These associations are presented graphically in Fig.  1 . A negative association was detected between 1,25 dihydroxyvitamin D and lumbar bone density (P ϭ 0.047), and a trend was observed for negative association between 1,25 dihydroxyvitamin D and thoracic bone density (P ϭ 0.083).
Discussion
The present study evaluated African-Americans with type 2 diabetes for association between circulating vitamin D and quantitative measures of CP in three vascular beds, four organ-specific adipose tissue depots, and vertebral BMD in the thoracic and lumbar spine. We confirm the recently reported negative association between VAT and 25-hydroxyvitamin D in African-Americans (31, 32) and observed similar trends for SAT and IMAT. An important novel positive association was detected between serum 25-hydroxyvitamin D concentrations and both carotid artery CP and infrarenal aorta CP in our sample of persons with diabetes. It is unknown whether positive associations exist between vitamin D and CP in African-Americans lacking diabetes; however, there is no a priori reason to expect differences in this relationship based on the presence of diabetes.
Whereas calcified atherosclerotic plaque documents the presence of subclinical atherosclerosis and coronary artery CP is predictive of future cardiovascular events in European-Americans, Asian-Americans, and AfricanAmericans (40), our study suggests that the relationship between 25-hydroxyvitamin D and subclinical atherosclerosis in African-Americans is unique. Higher levels of 25-hydroxyvitamin D seem to be positively associated with aorta and carotid CP in African-Americans but not with coronary CP. These results contradict what is observed in individuals of European descent. Studies in Amish, European-American (Health Professionals Follow-Up Study), and Italian participants reveal that 25-hydroxyvitamin D concentrations are inversely associated with subclinical atherosclerosis as measured by CP or carotid intima-media thickness (41) (42) (43) (44) . In the MESA study [comprising European-Americans, Asian (Chinese)-Americans, African-Americans, and Hispanic-Americans] and in the Amish, lower 25-hydroxyvitamin D concentrations were not associated with prevalent coronary CP, but lower vitamin D levels were associated with increasing risk for incident coronary CP in MESA participants after adjusting for age, gender, and ethnicity (41, 44) . We observed a significant positive association between 25-hydroxyvitamin D and both aorta CP and carotid artery CP in the present analyses in African-Americans. Additionally, we detected no evidence of association between hsCRP and CP, VAT, PAT, SAT, or bone density in this AfricanAmerican sample. These results led us to reconsider the role of 25-hydroxyvitamin D replacement in African-Americans with vitamin D insufficiency. Current practice encourages vitamin D replacement in those with low levels because this is presumed to be protective from (and serve as a treatment for) osteopenia and osteoporosis. Vitamin D supplementation has also been postulated to favor cardiovascular health (45) . In theory, vitamin D-induced prevention of osteopenia should also be associated with lower levels of CP. However, the inverse relationship between bone mineralization and CP appeared to be weaker in AfricanAmericans than European-Americans, assuming preserved kidney function, although relatively small numbers of African-American subjects were evaluated (46) . The effects of vitamin D supplementation on development and progression of CP remain unknown (47) , and it would not be unexpected to see differential effects of supplementation based on ethnicity (48) .
In a study including 208 postmenopausal AfricanAmerican women with 25-hydroxyvitamin D levels less than 49.9 nmol/liter (Ͻ20 ng/ml), Aloia et al. (49) performed a randomized controlled trial comparing vitamin D plus calcium supplementation to calcium supplementation alone. In these calcium-replete women, no effects of vitamin D supplementation were seen on the rate of bone loss or bone turnover after 3 yr, nor were differences detected in urinary calcium excretion, PTH levels, or rates of nephrolithiasis. Supplemental vitamin D and calcium in Women's Health Initiative participants (9.1% AfricanAmerican) improved hip BMD and increased kidney stones, without significant effects on hip fracture or total or cardiovascular mortality (50) . A follow-up Women's Health Initiative report demonstrated nonsignificant reductions in total mortality among postmenopausal women receiving supplemental vitamin D (51) . A metaanalysis evaluating 57,311 frail elderly postmenopausal women in 18 randomized controlled trials also detected significant reductions in total mortality with supplemental vitamin D, although the impact of ethnicity, baseline vitamin D level, and vitamin D dosage were not assessed (23) . Ethnic differences in the relationship between vitamin D levels and atherosclerosis remain important to determine because epidemiological studies revealed consis- jcem.endojournals.orgtent ethnic differences in CP (5-9) and rates of myocardial infarction in those with equal access to medical care (52) (53) (54) . African-Americans were at lower risk than EuropeanAmericans, despite presence of more severe cardiovascular disease risk factors. An important limitation of this and other studies with CT-derived measures of CP are their cross-sectional nature. In the future, it will be important to quantify vitamin D levels and their associations with adiposity and CTderived CP in longitudinal studies containing large numbers of African-American participants.
In conclusion, VAT and 25-hydroxyvitamin D are significantly and negatively associated in African-Americans with diabetes. In contrast, significant positive associations are observed between 25-hydroxyvitamin D and both carotid artery CP and aorta CP. The direct relationship between vitamin D and quantity of CP in African-Americans may differ from that in European-derived populations, in which lower vitamin D levels appear to be associated with excess risks for atherosclerotic cardiovascular disease and osteoporosis. Until long-term safety studies are performed, the effect of supplementing vitamin D on atherosclerosis in African-Americans with vitamin D deficiency remains unknown. In addition, the normal range for serum concentrations of 25-hydroxyvitamin D may differ based on ethnicity and needs to be determined in the African-American population.
